BRCA1 and breast cancer: RRM can reduce the risk of developing BC in BRCA1 carriers by more than 90% (Meijers-Heijboer et al., 2001; Heemskerk-Gerritsen et al., 2013; Li et al., 2016) and even reduce mortality from any cause (Honold and Camus, 2018).